| |
|
|
|
Poseida Therapeutics Inc  
|
|
11.91 0.83 (0.07%) |
02-25 16:00 |
|
Open: |
11.06 |
Pre close: |
11.08 |
Target:
|
15.93
|
|
High: |
12.9 |
Low: |
11.06 |
Resistance:
|
13.64
15.93
|
|
Volume: |
529,820 |
Market Cap: |
736M |
Support:
|
10.41
8.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
11.09
 |
MACD |
MACD(12,26):
|
0.46 |
|
MA(20): |
9.90 |
Signal(12,26,9): |
0.23 |
|
MA(100): |
10.22 |
Stochastic Oscillator |
%K(14,3):
|
49.76  |
|
MA(250): |
0.00 |
%D(3): |
58.65 |
|
Average Volume(K) |
3-Month: |
32530
|
52-Week |
High:
|
17.62 |
|
10-Days: |
54889 |
Low: |
7.63 |
|
RSI |
RSI(14):
|
64.83 |
Change(%): |
-22.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
61.82 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
31.81 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
15.14 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
41.28 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1630 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-1.819 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-99.45 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-7.40 |
|
|
|
|
|
|
